nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP3A5—Rosuvastatin—atherosclerosis	0.0492	0.0773	CbGbCtD
Pentamidine—CYP3A5—Simvastatin—atherosclerosis	0.0457	0.0718	CbGbCtD
Pentamidine—CYP3A5—Pravastatin—atherosclerosis	0.0447	0.0703	CbGbCtD
Pentamidine—CYP3A5—Lovastatin—atherosclerosis	0.0447	0.0703	CbGbCtD
Pentamidine—CYP2C8—Simvastatin—atherosclerosis	0.044	0.0691	CbGbCtD
Pentamidine—CYP2C8—Pravastatin—atherosclerosis	0.043	0.0676	CbGbCtD
Pentamidine—CYP2C8—Lovastatin—atherosclerosis	0.043	0.0676	CbGbCtD
Pentamidine—CYP2C19—Rosuvastatin—atherosclerosis	0.0397	0.0623	CbGbCtD
Pentamidine—CYP2C19—Simvastatin—atherosclerosis	0.0369	0.0579	CbGbCtD
Pentamidine—CYP2C19—Lovastatin—atherosclerosis	0.0361	0.0567	CbGbCtD
Pentamidine—CYP2D6—Niacin—atherosclerosis	0.0355	0.0557	CbGbCtD
Pentamidine—CYP2D6—Simvastatin—atherosclerosis	0.028	0.0441	CbGbCtD
Pentamidine—CYP2D6—Pravastatin—atherosclerosis	0.0274	0.0431	CbGbCtD
Pentamidine—CYP2D6—Lovastatin—atherosclerosis	0.0274	0.0431	CbGbCtD
Pentamidine—CYP3A4—Rosuvastatin—atherosclerosis	0.0192	0.0301	CbGbCtD
Pentamidine—CYP3A4—Ezetimibe—atherosclerosis	0.0192	0.0301	CbGbCtD
Pentamidine—CYP3A4—Simvastatin—atherosclerosis	0.0178	0.028	CbGbCtD
Pentamidine—CYP3A4—Lovastatin—atherosclerosis	0.0174	0.0274	CbGbCtD
Pentamidine—CYP3A4—Pravastatin—atherosclerosis	0.0174	0.0274	CbGbCtD
Pentamidine—S100B—artery—atherosclerosis	0.0073	0.197	CbGeAlD
Pentamidine—TRDMT1—cardiovascular system—atherosclerosis	0.00646	0.174	CbGeAlD
Pentamidine—S100B—blood vessel—atherosclerosis	0.00569	0.154	CbGeAlD
Pentamidine—AOC1—connective tissue—atherosclerosis	0.00334	0.0903	CbGeAlD
Pentamidine—S100B—connective tissue—atherosclerosis	0.00292	0.0787	CbGeAlD
Pentamidine—S100B—cardiovascular system—atherosclerosis	0.00254	0.0685	CbGeAlD
Pentamidine—Ospemifene—ESR1—atherosclerosis	0.00229	1	CrCbGaD
Pentamidine—S100B—adipose tissue—atherosclerosis	0.00224	0.0604	CbGeAlD
Pentamidine—AOC1—liver—atherosclerosis	0.0018	0.0486	CbGeAlD
Pentamidine—CYP4A11—liver—atherosclerosis	0.00149	0.0404	CbGeAlD
Pentamidine—Sinusitis—Pravastatin—atherosclerosis	0.000519	0.00266	CcSEcCtD
Pentamidine—Arthralgia—Rosuvastatin—atherosclerosis	0.000514	0.00263	CcSEcCtD
Pentamidine—Myalgia—Rosuvastatin—atherosclerosis	0.000514	0.00263	CcSEcCtD
Pentamidine—Flushing—Simvastatin—atherosclerosis	0.00051	0.00261	CcSEcCtD
Pentamidine—Rhinitis—Niacin—atherosclerosis	0.000506	0.00259	CcSEcCtD
Pentamidine—Hepatitis—Niacin—atherosclerosis	0.000504	0.00258	CcSEcCtD
Pentamidine—Hypoaesthesia—Niacin—atherosclerosis	0.000502	0.00257	CcSEcCtD
Pentamidine—Erythema—Ezetimibe—atherosclerosis	0.000501	0.00257	CcSEcCtD
Pentamidine—Dysgeusia—Lovastatin—atherosclerosis	0.000501	0.00256	CcSEcCtD
Pentamidine—Rhinitis—Pravastatin—atherosclerosis	0.000498	0.00255	CcSEcCtD
Pentamidine—Oedema peripheral—Niacin—atherosclerosis	0.000497	0.00254	CcSEcCtD
Pentamidine—Hepatitis—Pravastatin—atherosclerosis	0.000497	0.00254	CcSEcCtD
Pentamidine—Confusional state—Rosuvastatin—atherosclerosis	0.000496	0.00254	CcSEcCtD
Pentamidine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000494	0.00253	CcSEcCtD
Pentamidine—Pharyngitis—Pravastatin—atherosclerosis	0.000493	0.00252	CcSEcCtD
Pentamidine—Chills—Simvastatin—atherosclerosis	0.000493	0.00252	CcSEcCtD
Pentamidine—Infection—Rosuvastatin—atherosclerosis	0.000489	0.0025	CcSEcCtD
Pentamidine—CYP1A1—adipose tissue—atherosclerosis	0.000483	0.0131	CbGeAlD
Pentamidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000482	0.00247	CcSEcCtD
Pentamidine—Vision blurred—Lovastatin—atherosclerosis	0.000482	0.00247	CcSEcCtD
Pentamidine—Tremor—Lovastatin—atherosclerosis	0.000479	0.00245	CcSEcCtD
Pentamidine—Erythema—Simvastatin—atherosclerosis	0.000478	0.00245	CcSEcCtD
Pentamidine—CYP3A5—adipose tissue—atherosclerosis	0.000473	0.0128	CbGeAlD
Pentamidine—Erythema multiforme—Pravastatin—atherosclerosis	0.00047	0.0024	CcSEcCtD
Pentamidine—Dysgeusia—Simvastatin—atherosclerosis	0.000468	0.0024	CcSEcCtD
Pentamidine—Flushing—Niacin—atherosclerosis	0.000468	0.0024	CcSEcCtD
Pentamidine—Angioedema—Lovastatin—atherosclerosis	0.000467	0.00239	CcSEcCtD
Pentamidine—Anaemia—Ezetimibe—atherosclerosis	0.000463	0.00237	CcSEcCtD
Pentamidine—Flushing—Pravastatin—atherosclerosis	0.000461	0.00236	CcSEcCtD
Pentamidine—Vertigo—Lovastatin—atherosclerosis	0.000459	0.00235	CcSEcCtD
Pentamidine—Angioedema—Ezetimibe—atherosclerosis	0.000458	0.00235	CcSEcCtD
Pentamidine—Leukopenia—Lovastatin—atherosclerosis	0.000458	0.00234	CcSEcCtD
Pentamidine—Chills—Niacin—atherosclerosis	0.000453	0.00232	CcSEcCtD
Pentamidine—Vision blurred—Simvastatin—atherosclerosis	0.000451	0.00231	CcSEcCtD
Pentamidine—Arrhythmia—Niacin—atherosclerosis	0.000451	0.00231	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000449	0.0023	CcSEcCtD
Pentamidine—Tremor—Simvastatin—atherosclerosis	0.000448	0.00229	CcSEcCtD
Pentamidine—Chills—Pravastatin—atherosclerosis	0.000446	0.00228	CcSEcCtD
Pentamidine—Insomnia—Rosuvastatin—atherosclerosis	0.000445	0.00228	CcSEcCtD
Pentamidine—Arrhythmia—Pravastatin—atherosclerosis	0.000444	0.00227	CcSEcCtD
Pentamidine—Palpitations—Ezetimibe—atherosclerosis	0.000443	0.00227	CcSEcCtD
Pentamidine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000442	0.00226	CcSEcCtD
Pentamidine—Anaemia—Simvastatin—atherosclerosis	0.000442	0.00226	CcSEcCtD
Pentamidine—Erythema—Niacin—atherosclerosis	0.000439	0.00225	CcSEcCtD
Pentamidine—Cough—Ezetimibe—atherosclerosis	0.000438	0.00224	CcSEcCtD
Pentamidine—Angioedema—Simvastatin—atherosclerosis	0.000437	0.00224	CcSEcCtD
Pentamidine—Arthralgia—Lovastatin—atherosclerosis	0.000435	0.00223	CcSEcCtD
Pentamidine—Chest pain—Lovastatin—atherosclerosis	0.000435	0.00223	CcSEcCtD
Pentamidine—Myalgia—Lovastatin—atherosclerosis	0.000435	0.00223	CcSEcCtD
Pentamidine—Anxiety—Lovastatin—atherosclerosis	0.000434	0.00222	CcSEcCtD
Pentamidine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000433	0.00222	CcSEcCtD
Pentamidine—Hypertension—Ezetimibe—atherosclerosis	0.000433	0.00222	CcSEcCtD
Pentamidine—Tension—Niacin—atherosclerosis	0.000431	0.00221	CcSEcCtD
Pentamidine—Discomfort—Lovastatin—atherosclerosis	0.00043	0.0022	CcSEcCtD
Pentamidine—Vertigo—Simvastatin—atherosclerosis	0.00043	0.0022	CcSEcCtD
Pentamidine—Leukopenia—Simvastatin—atherosclerosis	0.000428	0.00219	CcSEcCtD
Pentamidine—Chest pain—Ezetimibe—atherosclerosis	0.000427	0.00219	CcSEcCtD
Pentamidine—Myalgia—Ezetimibe—atherosclerosis	0.000427	0.00219	CcSEcCtD
Pentamidine—Arthralgia—Ezetimibe—atherosclerosis	0.000427	0.00219	CcSEcCtD
Pentamidine—Nervousness—Niacin—atherosclerosis	0.000426	0.00218	CcSEcCtD
Pentamidine—Dry mouth—Lovastatin—atherosclerosis	0.000426	0.00218	CcSEcCtD
Pentamidine—Tension—Pravastatin—atherosclerosis	0.000424	0.00217	CcSEcCtD
Pentamidine—Dysgeusia—Pravastatin—atherosclerosis	0.000423	0.00217	CcSEcCtD
Pentamidine—Discomfort—Ezetimibe—atherosclerosis	0.000422	0.00216	CcSEcCtD
Pentamidine—Pain—Rosuvastatin—atherosclerosis	0.000421	0.00216	CcSEcCtD
Pentamidine—Constipation—Rosuvastatin—atherosclerosis	0.000421	0.00216	CcSEcCtD
Pentamidine—CYP2C19—liver—atherosclerosis	0.000421	0.0114	CbGeAlD
Pentamidine—Confusional state—Lovastatin—atherosclerosis	0.000421	0.00215	CcSEcCtD
Pentamidine—Nervousness—Pravastatin—atherosclerosis	0.00042	0.00215	CcSEcCtD
Pentamidine—Dry mouth—Ezetimibe—atherosclerosis	0.000418	0.00214	CcSEcCtD
Pentamidine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000417	0.00214	CcSEcCtD
Pentamidine—Infection—Lovastatin—atherosclerosis	0.000415	0.00212	CcSEcCtD
Pentamidine—Vision blurred—Niacin—atherosclerosis	0.000414	0.00212	CcSEcCtD
Pentamidine—Confusional state—Ezetimibe—atherosclerosis	0.000413	0.00211	CcSEcCtD
Pentamidine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000409	0.0021	CcSEcCtD
Pentamidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000409	0.00209	CcSEcCtD
Pentamidine—Vision blurred—Pravastatin—atherosclerosis	0.000407	0.00209	CcSEcCtD
Pentamidine—Myalgia—Simvastatin—atherosclerosis	0.000407	0.00208	CcSEcCtD
Pentamidine—Chest pain—Simvastatin—atherosclerosis	0.000407	0.00208	CcSEcCtD
Pentamidine—Arthralgia—Simvastatin—atherosclerosis	0.000407	0.00208	CcSEcCtD
Pentamidine—Infection—Ezetimibe—atherosclerosis	0.000407	0.00208	CcSEcCtD
Pentamidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000406	0.00208	CcSEcCtD
Pentamidine—Anxiety—Simvastatin—atherosclerosis	0.000406	0.00208	CcSEcCtD
Pentamidine—Tremor—Pravastatin—atherosclerosis	0.000405	0.00207	CcSEcCtD
Pentamidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000403	0.00206	CcSEcCtD
Pentamidine—Discomfort—Simvastatin—atherosclerosis	0.000402	0.00206	CcSEcCtD
Pentamidine—Angioedema—Niacin—atherosclerosis	0.000401	0.00205	CcSEcCtD
Pentamidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000401	0.00205	CcSEcCtD
Pentamidine—Anaemia—Pravastatin—atherosclerosis	0.0004	0.00205	CcSEcCtD
Pentamidine—Anorexia—Lovastatin—atherosclerosis	0.000398	0.00204	CcSEcCtD
Pentamidine—Angioedema—Pravastatin—atherosclerosis	0.000395	0.00202	CcSEcCtD
Pentamidine—Vertigo—Niacin—atherosclerosis	0.000394	0.00202	CcSEcCtD
Pentamidine—Syncope—Niacin—atherosclerosis	0.000394	0.00202	CcSEcCtD
Pentamidine—Confusional state—Simvastatin—atherosclerosis	0.000394	0.00201	CcSEcCtD
Pentamidine—Leukopenia—Niacin—atherosclerosis	0.000393	0.00201	CcSEcCtD
Pentamidine—Urticaria—Rosuvastatin—atherosclerosis	0.000391	0.002	CcSEcCtD
Pentamidine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00039	0.002	CcSEcCtD
Pentamidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000389	0.00199	CcSEcCtD
Pentamidine—Vertigo—Pravastatin—atherosclerosis	0.000388	0.00199	CcSEcCtD
Pentamidine—Palpitations—Niacin—atherosclerosis	0.000388	0.00199	CcSEcCtD
Pentamidine—Infection—Simvastatin—atherosclerosis	0.000388	0.00198	CcSEcCtD
Pentamidine—Leukopenia—Pravastatin—atherosclerosis	0.000387	0.00198	CcSEcCtD
Pentamidine—Loss of consciousness—Niacin—atherosclerosis	0.000386	0.00198	CcSEcCtD
Pentamidine—Cough—Niacin—atherosclerosis	0.000383	0.00196	CcSEcCtD
Pentamidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000382	0.00196	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00038	0.00195	CcSEcCtD
Pentamidine—Insomnia—Lovastatin—atherosclerosis	0.000377	0.00193	CcSEcCtD
Pentamidine—Cough—Pravastatin—atherosclerosis	0.000377	0.00193	CcSEcCtD
Pentamidine—Paraesthesia—Lovastatin—atherosclerosis	0.000375	0.00192	CcSEcCtD
Pentamidine—Myalgia—Niacin—atherosclerosis	0.000374	0.00191	CcSEcCtD
Pentamidine—Arthralgia—Niacin—atherosclerosis	0.000374	0.00191	CcSEcCtD
Pentamidine—Hypertension—Pravastatin—atherosclerosis	0.000373	0.00191	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000373	0.00191	CcSEcCtD
Pentamidine—Anorexia—Simvastatin—atherosclerosis	0.000372	0.0019	CcSEcCtD
Pentamidine—Dyspnoea—Lovastatin—atherosclerosis	0.000372	0.0019	CcSEcCtD
Pentamidine—Insomnia—Ezetimibe—atherosclerosis	0.00037	0.00189	CcSEcCtD
Pentamidine—Arthralgia—Pravastatin—atherosclerosis	0.000368	0.00188	CcSEcCtD
Pentamidine—Myalgia—Pravastatin—atherosclerosis	0.000368	0.00188	CcSEcCtD
Pentamidine—Chest pain—Pravastatin—atherosclerosis	0.000368	0.00188	CcSEcCtD
Pentamidine—Paraesthesia—Ezetimibe—atherosclerosis	0.000367	0.00188	CcSEcCtD
Pentamidine—Dyspepsia—Lovastatin—atherosclerosis	0.000367	0.00188	CcSEcCtD
Pentamidine—CYP2C8—liver—atherosclerosis	0.000367	0.00992	CbGeAlD
Pentamidine—Anxiety—Pravastatin—atherosclerosis	0.000367	0.00188	CcSEcCtD
Pentamidine—Dry mouth—Niacin—atherosclerosis	0.000366	0.00187	CcSEcCtD
Pentamidine—Dyspnoea—Ezetimibe—atherosclerosis	0.000365	0.00187	CcSEcCtD
Pentamidine—Discomfort—Pravastatin—atherosclerosis	0.000364	0.00186	CcSEcCtD
Pentamidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000363	0.00186	CcSEcCtD
Pentamidine—Decreased appetite—Lovastatin—atherosclerosis	0.000363	0.00186	CcSEcCtD
Pentamidine—Dyspepsia—Ezetimibe—atherosclerosis	0.00036	0.00184	CcSEcCtD
Pentamidine—Fatigue—Lovastatin—atherosclerosis	0.00036	0.00184	CcSEcCtD
Pentamidine—Anaphylactic shock—Niacin—atherosclerosis	0.000358	0.00183	CcSEcCtD
Pentamidine—Pain—Lovastatin—atherosclerosis	0.000357	0.00183	CcSEcCtD
Pentamidine—Constipation—Lovastatin—atherosclerosis	0.000357	0.00183	CcSEcCtD
Pentamidine—Confusional state—Pravastatin—atherosclerosis	0.000356	0.00182	CcSEcCtD
Pentamidine—Decreased appetite—Ezetimibe—atherosclerosis	0.000356	0.00182	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000356	0.00182	CcSEcCtD
Pentamidine—Asthenia—Rosuvastatin—atherosclerosis	0.000353	0.00181	CcSEcCtD
Pentamidine—Insomnia—Simvastatin—atherosclerosis	0.000353	0.00181	CcSEcCtD
Pentamidine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000353	0.00181	CcSEcCtD
Pentamidine—Fatigue—Ezetimibe—atherosclerosis	0.000353	0.00181	CcSEcCtD
Pentamidine—Shock—Niacin—atherosclerosis	0.000353	0.0018	CcSEcCtD
Pentamidine—Infection—Pravastatin—atherosclerosis	0.000351	0.00179	CcSEcCtD
Pentamidine—Paraesthesia—Simvastatin—atherosclerosis	0.00035	0.00179	CcSEcCtD
Pentamidine—Constipation—Ezetimibe—atherosclerosis	0.00035	0.00179	CcSEcCtD
Pentamidine—Pain—Ezetimibe—atherosclerosis	0.00035	0.00179	CcSEcCtD
Pentamidine—Tachycardia—Niacin—atherosclerosis	0.00035	0.00179	CcSEcCtD
Pentamidine—Pruritus—Rosuvastatin—atherosclerosis	0.000348	0.00178	CcSEcCtD
Pentamidine—Dyspnoea—Simvastatin—atherosclerosis	0.000348	0.00178	CcSEcCtD
Pentamidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000345	0.00177	CcSEcCtD
Pentamidine—Feeling abnormal—Lovastatin—atherosclerosis	0.000344	0.00176	CcSEcCtD
Pentamidine—CYP1A2—liver—atherosclerosis	0.000344	0.00928	CbGeAlD
Pentamidine—Dyspepsia—Simvastatin—atherosclerosis	0.000344	0.00176	CcSEcCtD
Pentamidine—Anorexia—Niacin—atherosclerosis	0.000342	0.00175	CcSEcCtD
Pentamidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000341	0.00175	CcSEcCtD
Pentamidine—Decreased appetite—Simvastatin—atherosclerosis	0.000339	0.00174	CcSEcCtD
Pentamidine—CYP1A1—liver—atherosclerosis	0.000339	0.00916	CbGeAlD
Pentamidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000337	0.00173	CcSEcCtD
Pentamidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000337	0.00172	CcSEcCtD
Pentamidine—Fatigue—Simvastatin—atherosclerosis	0.000336	0.00172	CcSEcCtD
Pentamidine—Anorexia—Pravastatin—atherosclerosis	0.000336	0.00172	CcSEcCtD
Pentamidine—Hypotension—Niacin—atherosclerosis	0.000335	0.00171	CcSEcCtD
Pentamidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000335	0.00171	CcSEcCtD
Pentamidine—Constipation—Simvastatin—atherosclerosis	0.000334	0.00171	CcSEcCtD
Pentamidine—Pain—Simvastatin—atherosclerosis	0.000334	0.00171	CcSEcCtD
Pentamidine—Urticaria—Lovastatin—atherosclerosis	0.000331	0.0017	CcSEcCtD
Pentamidine—CYP3A5—liver—atherosclerosis	0.000331	0.00895	CbGeAlD
Pentamidine—Body temperature increased—Lovastatin—atherosclerosis	0.00033	0.00169	CcSEcCtD
Pentamidine—Abdominal pain—Lovastatin—atherosclerosis	0.00033	0.00169	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000326	0.00167	CcSEcCtD
Pentamidine—Dizziness—Rosuvastatin—atherosclerosis	0.000326	0.00167	CcSEcCtD
Pentamidine—Urticaria—Ezetimibe—atherosclerosis	0.000325	0.00166	CcSEcCtD
Pentamidine—Insomnia—Niacin—atherosclerosis	0.000324	0.00166	CcSEcCtD
Pentamidine—Abdominal pain—Ezetimibe—atherosclerosis	0.000324	0.00166	CcSEcCtD
Pentamidine—Body temperature increased—Ezetimibe—atherosclerosis	0.000324	0.00166	CcSEcCtD
Pentamidine—Paraesthesia—Niacin—atherosclerosis	0.000322	0.00165	CcSEcCtD
Pentamidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000322	0.00165	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000321	0.00165	CcSEcCtD
Pentamidine—Dyspnoea—Niacin—atherosclerosis	0.000319	0.00164	CcSEcCtD
Pentamidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000319	0.00163	CcSEcCtD
Pentamidine—Insomnia—Pravastatin—atherosclerosis	0.000319	0.00163	CcSEcCtD
Pentamidine—Somnolence—Niacin—atherosclerosis	0.000319	0.00163	CcSEcCtD
Pentamidine—Paraesthesia—Pravastatin—atherosclerosis	0.000317	0.00162	CcSEcCtD
Pentamidine—Dyspepsia—Niacin—atherosclerosis	0.000315	0.00161	CcSEcCtD
Pentamidine—Dyspnoea—Pravastatin—atherosclerosis	0.000315	0.00161	CcSEcCtD
Pentamidine—Decreased appetite—Niacin—atherosclerosis	0.000312	0.00159	CcSEcCtD
Pentamidine—Dyspepsia—Pravastatin—atherosclerosis	0.000311	0.00159	CcSEcCtD
Pentamidine—Rash—Rosuvastatin—atherosclerosis	0.00031	0.00159	CcSEcCtD
Pentamidine—Dermatitis—Rosuvastatin—atherosclerosis	0.00031	0.00159	CcSEcCtD
Pentamidine—Urticaria—Simvastatin—atherosclerosis	0.00031	0.00159	CcSEcCtD
Pentamidine—Abdominal pain—Simvastatin—atherosclerosis	0.000309	0.00158	CcSEcCtD
Pentamidine—Body temperature increased—Simvastatin—atherosclerosis	0.000309	0.00158	CcSEcCtD
Pentamidine—Headache—Rosuvastatin—atherosclerosis	0.000308	0.00158	CcSEcCtD
Pentamidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000307	0.00157	CcSEcCtD
Pentamidine—Decreased appetite—Pravastatin—atherosclerosis	0.000307	0.00157	CcSEcCtD
Pentamidine—Pain—Niacin—atherosclerosis	0.000306	0.00157	CcSEcCtD
Pentamidine—Fatigue—Pravastatin—atherosclerosis	0.000304	0.00156	CcSEcCtD
Pentamidine—Constipation—Pravastatin—atherosclerosis	0.000302	0.00154	CcSEcCtD
Pentamidine—Pain—Pravastatin—atherosclerosis	0.000302	0.00154	CcSEcCtD
Pentamidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000302	0.00154	CcSEcCtD
Pentamidine—Asthenia—Lovastatin—atherosclerosis	0.000299	0.00153	CcSEcCtD
Pentamidine—Pruritus—Lovastatin—atherosclerosis	0.000295	0.00151	CcSEcCtD
Pentamidine—Asthenia—Ezetimibe—atherosclerosis	0.000294	0.0015	CcSEcCtD
Pentamidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000293	0.0015	CcSEcCtD
Pentamidine—Nausea—Rosuvastatin—atherosclerosis	0.000292	0.0015	CcSEcCtD
Pentamidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000291	0.00149	CcSEcCtD
Pentamidine—Pruritus—Ezetimibe—atherosclerosis	0.00029	0.00148	CcSEcCtD
Pentamidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000289	0.00148	CcSEcCtD
Pentamidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000288	0.00147	CcSEcCtD
Pentamidine—Diarrhoea—Lovastatin—atherosclerosis	0.000285	0.00146	CcSEcCtD
Pentamidine—Urticaria—Niacin—atherosclerosis	0.000285	0.00146	CcSEcCtD
Pentamidine—Body temperature increased—Niacin—atherosclerosis	0.000283	0.00145	CcSEcCtD
Pentamidine—Abdominal pain—Niacin—atherosclerosis	0.000283	0.00145	CcSEcCtD
Pentamidine—Urticaria—Pravastatin—atherosclerosis	0.00028	0.00143	CcSEcCtD
Pentamidine—Asthenia—Simvastatin—atherosclerosis	0.00028	0.00143	CcSEcCtD
Pentamidine—Diarrhoea—Ezetimibe—atherosclerosis	0.00028	0.00143	CcSEcCtD
Pentamidine—Body temperature increased—Pravastatin—atherosclerosis	0.000279	0.00143	CcSEcCtD
Pentamidine—Abdominal pain—Pravastatin—atherosclerosis	0.000279	0.00143	CcSEcCtD
Pentamidine—Pruritus—Simvastatin—atherosclerosis	0.000276	0.00141	CcSEcCtD
Pentamidine—Dizziness—Lovastatin—atherosclerosis	0.000276	0.00141	CcSEcCtD
Pentamidine—Dizziness—Ezetimibe—atherosclerosis	0.000271	0.00139	CcSEcCtD
Pentamidine—Diarrhoea—Simvastatin—atherosclerosis	0.000267	0.00137	CcSEcCtD
Pentamidine—Vomiting—Lovastatin—atherosclerosis	0.000265	0.00136	CcSEcCtD
Pentamidine—Hypersensitivity—Niacin—atherosclerosis	0.000264	0.00135	CcSEcCtD
Pentamidine—Rash—Lovastatin—atherosclerosis	0.000263	0.00135	CcSEcCtD
Pentamidine—Dermatitis—Lovastatin—atherosclerosis	0.000263	0.00135	CcSEcCtD
Pentamidine—Headache—Lovastatin—atherosclerosis	0.000261	0.00134	CcSEcCtD
Pentamidine—Vomiting—Ezetimibe—atherosclerosis	0.00026	0.00133	CcSEcCtD
Pentamidine—Hypersensitivity—Pravastatin—atherosclerosis	0.00026	0.00133	CcSEcCtD
Pentamidine—Dizziness—Simvastatin—atherosclerosis	0.000258	0.00132	CcSEcCtD
Pentamidine—Rash—Ezetimibe—atherosclerosis	0.000258	0.00132	CcSEcCtD
Pentamidine—Dermatitis—Ezetimibe—atherosclerosis	0.000258	0.00132	CcSEcCtD
Pentamidine—Asthenia—Niacin—atherosclerosis	0.000257	0.00132	CcSEcCtD
Pentamidine—Headache—Ezetimibe—atherosclerosis	0.000256	0.00131	CcSEcCtD
Pentamidine—Pruritus—Niacin—atherosclerosis	0.000254	0.0013	CcSEcCtD
Pentamidine—Asthenia—Pravastatin—atherosclerosis	0.000253	0.0013	CcSEcCtD
Pentamidine—Pruritus—Pravastatin—atherosclerosis	0.00025	0.00128	CcSEcCtD
Pentamidine—CYP3A4—liver—atherosclerosis	0.000249	0.00672	CbGeAlD
Pentamidine—Vomiting—Simvastatin—atherosclerosis	0.000248	0.00127	CcSEcCtD
Pentamidine—Nausea—Lovastatin—atherosclerosis	0.000248	0.00127	CcSEcCtD
Pentamidine—Rash—Simvastatin—atherosclerosis	0.000246	0.00126	CcSEcCtD
Pentamidine—Dermatitis—Simvastatin—atherosclerosis	0.000246	0.00126	CcSEcCtD
Pentamidine—Diarrhoea—Niacin—atherosclerosis	0.000245	0.00126	CcSEcCtD
Pentamidine—CYP2D6—liver—atherosclerosis	0.000245	0.00661	CbGeAlD
Pentamidine—Headache—Simvastatin—atherosclerosis	0.000244	0.00125	CcSEcCtD
Pentamidine—Nausea—Ezetimibe—atherosclerosis	0.000243	0.00124	CcSEcCtD
Pentamidine—Diarrhoea—Pravastatin—atherosclerosis	0.000241	0.00124	CcSEcCtD
Pentamidine—Dizziness—Niacin—atherosclerosis	0.000237	0.00121	CcSEcCtD
Pentamidine—Dizziness—Pravastatin—atherosclerosis	0.000233	0.00119	CcSEcCtD
Pentamidine—Nausea—Simvastatin—atherosclerosis	0.000232	0.00119	CcSEcCtD
Pentamidine—Vomiting—Niacin—atherosclerosis	0.000228	0.00117	CcSEcCtD
Pentamidine—Rash—Niacin—atherosclerosis	0.000226	0.00116	CcSEcCtD
Pentamidine—Dermatitis—Niacin—atherosclerosis	0.000226	0.00116	CcSEcCtD
Pentamidine—Headache—Niacin—atherosclerosis	0.000224	0.00115	CcSEcCtD
Pentamidine—Vomiting—Pravastatin—atherosclerosis	0.000224	0.00115	CcSEcCtD
Pentamidine—Rash—Pravastatin—atherosclerosis	0.000222	0.00114	CcSEcCtD
Pentamidine—Dermatitis—Pravastatin—atherosclerosis	0.000222	0.00114	CcSEcCtD
Pentamidine—Headache—Pravastatin—atherosclerosis	0.000221	0.00113	CcSEcCtD
Pentamidine—Nausea—Niacin—atherosclerosis	0.000213	0.00109	CcSEcCtD
Pentamidine—Nausea—Pravastatin—atherosclerosis	0.00021	0.00107	CcSEcCtD
Pentamidine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.48e-05	0.000115	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.47e-05	0.000114	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA4—atherosclerosis	1.47e-05	0.000114	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NOS3—atherosclerosis	1.46e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CETP—atherosclerosis	1.45e-05	0.000113	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TGFB1—atherosclerosis	1.45e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.45e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.45e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.43e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.43e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LPA—atherosclerosis	1.43e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.42e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SCARB1—atherosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.38e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BGN—atherosclerosis	1.38e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.38e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—LIPC—atherosclerosis	1.38e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.38e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOC3—atherosclerosis	1.37e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.37e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—LDLR—atherosclerosis	1.37e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.36e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.34e-05	0.000104	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CETP—atherosclerosis	1.33e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—atherosclerosis	1.33e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.32e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.32e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.32e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.28e-05	9.97e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.28e-05	9.93e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.28e-05	9.91e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.27e-05	9.88e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.27e-05	9.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.27e-05	9.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.27e-05	9.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.27e-05	9.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.25e-05	9.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.25e-05	9.71e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.24e-05	9.65e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.24e-05	9.64e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.24e-05	9.63e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.23e-05	9.58e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.23e-05	9.58e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.23e-05	9.56e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.23e-05	9.52e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.22e-05	9.46e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LPA—atherosclerosis	1.21e-05	9.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.21e-05	9.36e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CETP—atherosclerosis	1.19e-05	9.24e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.19e-05	9.21e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.17e-05	9.1e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BGN—atherosclerosis	1.17e-05	9.1e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.16e-05	9.03e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.16e-05	9e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.16e-05	8.99e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.16e-05	8.99e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.14e-05	8.86e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.14e-05	8.85e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.14e-05	8.83e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.13e-05	8.81e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.13e-05	8.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.13e-05	8.75e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.12e-05	8.7e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.12e-05	8.67e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.12e-05	8.67e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.11e-05	8.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.1e-05	8.57e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CETP—atherosclerosis	1.09e-05	8.5e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.09e-05	8.49e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—atherosclerosis	1.09e-05	8.47e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.09e-05	8.47e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.09e-05	8.44e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.08e-05	8.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.08e-05	8.35e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.07e-05	8.34e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.06e-05	8.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.05e-05	8.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.03e-05	8.01e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOB—atherosclerosis	1.02e-05	7.92e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—atherosclerosis	1.01e-05	7.82e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.01e-05	7.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.96e-06	7.73e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—atherosclerosis	9.92e-06	7.7e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.9e-06	7.68e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.79e-06	7.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA2—atherosclerosis	9.79e-06	7.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.79e-06	7.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.79e-06	7.6e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—LPL—atherosclerosis	9.74e-06	7.56e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.71e-06	7.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.67e-06	7.51e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.67e-06	7.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOB—atherosclerosis	9.63e-06	7.48e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.62e-06	7.46e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LIPC—atherosclerosis	9.61e-06	7.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.59e-06	7.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOC3—atherosclerosis	9.55e-06	7.41e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GPX1—atherosclerosis	9.5e-06	7.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LDLR—atherosclerosis	9.49e-06	7.37e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—atherosclerosis	9.37e-06	7.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LPA—atherosclerosis	9.34e-06	7.25e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CETP—atherosclerosis	9.27e-06	7.2e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CD36—atherosclerosis	9.25e-06	7.18e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMOX1—atherosclerosis	9.22e-06	7.16e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—LPL—atherosclerosis	9.2e-06	7.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BGN—atherosclerosis	9.04e-06	7.02e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GPX1—atherosclerosis	8.97e-06	6.97e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.95e-06	6.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.88e-06	6.89e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOB—atherosclerosis	8.83e-06	6.86e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.82e-06	6.85e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.77e-06	6.8e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CD36—atherosclerosis	8.74e-06	6.78e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.65e-06	6.71e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.62e-06	6.69e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARA—atherosclerosis	8.6e-06	6.68e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.59e-06	6.67e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—LPL—atherosclerosis	8.43e-06	6.55e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.39e-06	6.51e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AGT—atherosclerosis	8.33e-06	6.47e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.32e-06	6.46e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—atherosclerosis	8.28e-06	6.43e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.23e-06	6.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GPX1—atherosclerosis	8.23e-06	6.39e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOE—atherosclerosis	8.16e-06	6.34e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARA—atherosclerosis	8.13e-06	6.31e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAV1—atherosclerosis	8.09e-06	6.28e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOA1—atherosclerosis	8.07e-06	6.26e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CD36—atherosclerosis	8.01e-06	6.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOB—atherosclerosis	7.88e-06	6.12e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AGT—atherosclerosis	7.87e-06	6.11e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOE—atherosclerosis	7.71e-06	5.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.67e-06	5.95e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAV1—atherosclerosis	7.64e-06	5.93e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOA1—atherosclerosis	7.62e-06	5.92e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.59e-06	5.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.57e-06	5.88e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.56e-06	5.87e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—LPL—atherosclerosis	7.53e-06	5.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.47e-06	5.8e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.46e-06	5.79e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARA—atherosclerosis	7.45e-06	5.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LIPC—atherosclerosis	7.42e-06	5.76e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOC3—atherosclerosis	7.37e-06	5.72e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.37e-06	5.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPX1—atherosclerosis	7.34e-06	5.7e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LDLR—atherosclerosis	7.33e-06	5.69e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOB—atherosclerosis	7.25e-06	5.63e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AGT—atherosclerosis	7.21e-06	5.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CETP—atherosclerosis	7.16e-06	5.56e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CD36—atherosclerosis	7.15e-06	5.55e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—atherosclerosis	7.11e-06	5.52e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOE—atherosclerosis	7.07e-06	5.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.05e-06	5.48e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAV1—atherosclerosis	7e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOA1—atherosclerosis	6.99e-06	5.42e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—INS—atherosclerosis	6.97e-06	5.41e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	6.96e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LPL—atherosclerosis	6.92e-06	5.37e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.85e-06	5.32e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.78e-06	5.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPX1—atherosclerosis	6.75e-06	5.24e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—atherosclerosis	6.72e-06	5.21e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—atherosclerosis	6.69e-06	5.19e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARA—atherosclerosis	6.65e-06	5.16e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—INS—atherosclerosis	6.59e-06	5.11e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CD36—atherosclerosis	6.58e-06	5.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.47e-06	5.02e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AGT—atherosclerosis	6.44e-06	5e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.41e-06	4.98e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—atherosclerosis	6.39e-06	4.96e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.38e-06	4.95e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOE—atherosclerosis	6.31e-06	4.9e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAV1—atherosclerosis	6.25e-06	4.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOA1—atherosclerosis	6.24e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.23e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—atherosclerosis	6.16e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOB—atherosclerosis	6.14e-06	4.77e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARA—atherosclerosis	6.12e-06	4.75e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NOS3—atherosclerosis	6.11e-06	4.75e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—INS—atherosclerosis	6.04e-06	4.69e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—atherosclerosis	6.04e-06	4.69e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.98e-06	4.64e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AGT—atherosclerosis	5.92e-06	4.6e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LPL—atherosclerosis	5.87e-06	4.55e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOE—atherosclerosis	5.8e-06	4.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NOS3—atherosclerosis	5.78e-06	4.48e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.77e-06	4.48e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAV1—atherosclerosis	5.75e-06	4.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOA1—atherosclerosis	5.74e-06	4.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPX1—atherosclerosis	5.72e-06	4.44e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.69e-06	4.42e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.59e-06	4.34e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CD36—atherosclerosis	5.57e-06	4.33e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—atherosclerosis	5.54e-06	4.3e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—atherosclerosis	5.5e-06	4.27e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—INS—atherosclerosis	5.39e-06	4.18e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NOS3—atherosclerosis	5.3e-06	4.11e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—atherosclerosis	5.28e-06	4.1e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.28e-06	4.1e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.24e-06	4.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARA—atherosclerosis	5.18e-06	4.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—atherosclerosis	5.06e-06	3.92e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AGT—atherosclerosis	5.02e-06	3.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—INS—atherosclerosis	4.96e-06	3.85e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.95e-06	3.84e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—atherosclerosis	4.94e-06	3.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOE—atherosclerosis	4.92e-06	3.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAV1—atherosclerosis	4.87e-06	3.78e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA1—atherosclerosis	4.86e-06	3.77e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.84e-06	3.76e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOB—atherosclerosis	4.74e-06	3.68e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NOS3—atherosclerosis	4.73e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.61e-06	3.58e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—atherosclerosis	4.55e-06	3.53e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LPL—atherosclerosis	4.53e-06	3.51e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.44e-06	3.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.42e-06	3.43e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.35e-06	3.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.32e-06	3.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CD36—atherosclerosis	4.3e-06	3.34e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.28e-06	3.32e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—INS—atherosclerosis	4.2e-06	3.26e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.08e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARA—atherosclerosis	4e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.98e-06	3.09e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AGT—atherosclerosis	3.87e-06	3.01e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—atherosclerosis	3.85e-06	2.99e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOE—atherosclerosis	3.79e-06	2.95e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.76e-06	2.92e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.75e-06	2.91e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.68e-06	2.86e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.42e-06	2.66e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.37e-06	2.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.31e-06	2.57e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—INS—atherosclerosis	3.24e-06	2.52e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—atherosclerosis	2.97e-06	2.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.84e-06	2.21e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—atherosclerosis	2.81e-06	2.18e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—atherosclerosis	2.66e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.6e-06	2.02e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—atherosclerosis	2.43e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.17e-06	1.69e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—atherosclerosis	2e-06	1.55e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.69e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.31e-06	1.01e-05	CbGpPWpGaD
